The anti-insulin trimolecular complex in type 1 diabetes

Curr Opin Endocrinol Diabetes Obes. 2010 Aug;17(4):329-34. doi: 10.1097/MED.0b013e32833aba41.

Abstract

Purpose of review: Description of the immunologic components needed for autoimmune diabetes.

Recent findings: The major histocompatability complex (MHC) class II molecules are the primary susceptibility genes for many autoimmune diseases, including type 1 diabetes. Understanding of the structural interaction between MHC molecules, antigenic peptides, and T-cell receptors (the three components of the trimolecular complex) has increased greatly over the past several years. The components of the anti-insulin trimolecular complex and findings that insulin is a key autoantigen in type 1 diabetes are reviewed.

Summary: The anti-insulin trimolecular complex is well defined in the nonobese diabetic mouse model. Insulin and specifically, the amino acid sequence 9 to 23 of the insulin B chain, represents a primary antigenic target for islet autoimmunity in the nonobese diabetic mouse model of type 1 diabetes with a specific mutation of this peptide preventing all diabetes. Initial studies suggest the human homologs of the anti-insulin trimolecular complex may be relevant in human disease.

Publication types

  • Review

MeSH terms

  • Animals
  • Autoantibodies / blood
  • Autoantibodies / physiology
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / immunology*
  • Humans
  • Insulin / immunology*
  • Insulin / metabolism
  • Macromolecular Substances / immunology*
  • Macromolecular Substances / metabolism
  • Major Histocompatibility Complex / immunology
  • Mice
  • Models, Biological
  • Receptors, Antigen, T-Cell / metabolism
  • Receptors, Antigen, T-Cell / physiology

Substances

  • Autoantibodies
  • Insulin
  • Macromolecular Substances
  • Receptors, Antigen, T-Cell